Haematological and biochemical parameters were monitored ill six patients during Intralipid hyperalimentation. A mild anaemia was consistently observed, accompanied by morphological changes in red cells, granulocytes, and platelets. All patients demonstrated an abnormally high percentage of plasma cholesterol in the unesterified form and altered plasma cholesterol esterifi cation, bllt red cells were not lIniformly enriched in cholesterol. These findings str ess the need for careflll monitoring during Intralipid therapy.
INTRODUCTION
The necessity for parenteral alimentation with a lipid based emulsion is well recognised when caloric intake is restricted for extended periods of time. lntralipid is an emulsion of soya bean oil (10 or 20% w/v), egg yolk phospholipid (1.2 % ), glycerol (2.5 %) and water, which has been widely used for this purpose. Favourable clinical experience with Intralipid R (Vitrum) has been reported, but certain side effects including small decreases in haematocrit and haemoglobin levels have been reported (Hansen, Hardie and Hidalgo 1976, Hallberg, Schuberth and Wretlind 1970) . During the past year, our experience with I ntralipid hyperalimentation has consistently documented this mild anaemia, accompanied by subtle alterations in the morphology of all three formed elements of the blood, as well as altered plasma cholesterol esterification.
The present report details these effects 111 six patients receiving parenteral Intralipid.
MATERIAL AND METHODS

j'miellls
Six patients were studied at Sydney Hospital while receiving total parenteral nutrition for a variety of underlying conditions (Table 1) . The hyperalimentation regimen consisted of Intralipid (10 or 20%) and an aqueous supplement of amino acids, vitamins, dextrose and electrolytes adjusted for individual needs. Hyperalimentation was continued for periods ranging from three weeks to three months. Biochemistry, haematology and peripheral blood smears were monitored through this period. Serum and red cell samples were analysed for lipids during the therapy period when morphology and haematology were abnormal, as described below.
LABORATORY METHODS
Serum samples were taken for routine biochemical analysis at varying times relative to Intralipid infusion. The serum transaminases, (AST and ALT), lactic dehydrogenase (LDH) and serum bilirubin were determined by (Neale, Aber and N ortham 1958) . Haematological parameters were determined in EDTA anticoagulated blood using the Coulter S automated cell counter. Platelet counts were determined by Coulter Thrombocounter. Fingerprick blood smears were examined on two occasions in order to exclude artifacts due to EDTA-lipid interaction. Blood smears were routinely examined by two experienced observers.
Plasma samples for red blood cell and plasma lipid analyses were taken several hours after the cessation of Intralipid infusion. Plasma total cholesterol and triglyceride concentrations were determined in isopropanol extracts using the AutoAnalyser R (Technicon Methods N-24a and N-78). Erythrocyte cholesterol was determined after chloroform methanol extraction of washed cells (Reed et al. 1960) . Lipoprotein fractions were analysed after separation of whole plasma in the preparative ultracentrifuge by standard techniques (Hatch and Lees 1968) . For the determination of free and esterified cholesterol, plasma samples were extracted according to Folch, Lees and Sloane Stanley (1957) and the cholesterol fractions separated by thin layer chromatography (TLC) (Goren and Simons 1977) . Lecithin cholesterol acyl transferase (LCAT) activity, a dynamic measure of plasma cholesterol esterification, was assayed in Anaesthesia and Intensive Care, Vol. VI, No. 4, November, 1978 plasma by the method of Stokke-Norum (Goren and Simons 1977, Stokke and Norum 1971) . Differences between means were assessed using Student's Hest (Snedecor and Cochran 1967) .
RESULTS
The haematological changes are summarised in Table 2 . All patients studied showed decrements in haemoglobin and haematocrit levels during Intralipid administration. This pattern is illustrated in Figure 1 . The anaemia frequently necessitated transfusion. During Intralipid therapy, concomitant with or prior to development of anaemia, all patients showed morphological changes in red cells, granulocytes and platelets. The red cells showed pseudo-agglutination and varying degrees of stomatocytosis and spherocytosis. The most unusual and consistent finding was the presence of red cells which had lost their membrane definition. We have termed this effect "reverse ghosting" ( Figure  2 ). Granulocytes similarly had lost membrane definition and were frequently seen to be disintegrating. Large morphologically abnormal platelets and mild thrombocytopenia were occasionally reported ( Figure 2) .
Changes in biochemical parameters are also summarized in Table 2 . The three patients showing the largest fall in haemoglobin and haematocrit also showed substantial elevations in serum transaminase and bilirubin levels. These indices were less affected in patients, F. R. and J. Mu. (Table 2 ) who had milder anaemic tendencies. The direct antiglobulin test and Heinz body preparation were both negative in the two patients tested.
There was considerable variation in the absolute levels of blood lipids observed. All patients had an abnormally high percentage of plasma cholesterol in the unesterified form at the same time that abnormal morphology was documented in peripheral smears (Table 1) . In three patients studied, the increased free cholesterol was largely confined to the low density lipoprotein (LDL) class (mean percent LDL free cholesterol (+-S.D.) 52 +-11 %, mean high density lipoprotein free cholesterol 30 ± 11 % ). These changes were not present in patients E.B. and W.N. when tested in the healthy state. Erythrocyte cholesterol levels tended to be elevated during Intralipid therapy relative to control values, but this response was well defined in only two patients ( Table   1 ) .
Five out of six patients had a reduced fractional rate of cholesterol esterification relative to controls (Table 1 ). The absolute rate of esterification was normal, due to expanded pools of free cholesterol. The fractional rate of esterification, measured in two patients off as well as on Intralipid therapy, indicated rates while off treatment which were nearly double those measured during therapy (11.0% vs. 6.4% per hour and 10.5% vs. 5.7% per hour).
DISCUSSION
Our experience with Intralipid administration documents reductions in haemoglobin concentration similar to those reported by Hallberg et al. (1970) . The concomitant morphological abnormalities of the formed elements of the blood described here have not to our knowledge been previously reported. Geyer (1970) has noted a tendency for red blood cell aggregation in experimental animals immediately after intravenous Intralipid, but without the residual effects noted here.
Although all patients showed some degree of anaemia and reticulocytosis, as well as bilirubinaemia during Intralipid administration, the precise nature of the anaemia cannot be conclusively defined. In general, anaemia was complicated by recent operative procedures, but the fact that "reverse ghosting" in peripheral blood smears and the development of anaemia and reticulocytosis occurred only during Intralipid therapy strongly implicates a membrane lability leading to haemolytic tendencies. Visible haemolysis in supernatant plasma was apparent in severe cases (e.g. W.N.), but parameters which normally help to establish the presence of haemolysis, e.g. haptoglobin, bilirubin, and LDH levels, were not helpful for technical and clinical reasons. Red cells also showing "reverse ghosting", as well as visible haemolysis in supernatant plasma, have been noted by us in a limited number of patients with primary Type V hyperlipidaemia (unpublished observations). This syndrome shares with Intralipid therapy a sustained flux of large, triglyceride rich particles.
Other abnormal red cells frequently observed during Intralipid therapy included stomatocytes and spherocytes. These red cell variants have also been observed associated with cirrhosis (Dacie and Lewis 1975) . Cirrhosis is also associated with alterations in serum and red cell free cholesterol and phospholipid concentrations (Cooper 1970 , Simons 1971 . The consistent increase in the proportion of plasma un esterified cholesterol reported here suggests that this lipid abnormality might initiate these red cell variants in an analogous manner. However, a causal relationship between plasma free cholesterol and the morphological abnormalities cannot be assumed, since cholesterol enrichment of the red cells was not consistently found. Similarly, two patients with type V hyperlipidaemia showing identical morphological changes and increased plasma free cholesterol had either normal (2.94 x 10-13 mmol/cell) or low (2.13 x 10-13 mmol/cell) levels of red cell cholesterol, in agreement with others (Bagdade and Ways 1970) . It would appear that despite the dynamic equilibrium which exists between plasma and red cell free cholesterol, red cell cholesterol does not directly reflect the total plasma free cholesterol level (Cooper et al. 1972) .
The red cell and plasma lipid abnormalities observed here may reflect hepatic dysfunction which developed as a result of therapy. Similar abnormalities in free cholesterol levels and cholesterol esterification known to occur in liver disease (Simons 1971 ) reinforce this possibility. Intralipid is known to be contraindicated in cases of primary liver disease. * At the critical stage when the need for Intralipid arises, consideration of the vulnerability of a patient to iatrogenic disease is frequently secondary to the need to administer life-saving therapy. The consistent occurrence of these significant changes in haematological and biochemical parameters during Intralipid hyperalimentation emphasises the need for careful patient monitoring throughout treatment.
